Mechanisms linking leptin to arterial and venous thrombosis: Potential pharmacological targets

Current Pharmaceutical Design

Volumn 20, Issue 4, 2014, Pages 635-640

  Schäfer, Katrin ^a   Konstantinides, Stavros ^b,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Adipokines; Cardiovascular risk; Leptin; Obesity; Platelets; Thrombosis

Indexed keywords

LEPTIN;

ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; BONE MARROW CELL; CARDIOVASCULAR RISK; CLINICAL STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESISTANCE; DRUG TARGETING; FIBRINOLYSIS; HUMAN; HYPERLEPTINEMIA; INFLAMMATORY CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE; THROMBOSIS; VASCULAR BIOLOGY; VEIN THROMBOSIS;

ANIMALS; ANTICOAGULANTS; ARTERIES; HUMANS; LEPTIN; MODELS, CARDIOVASCULAR; MOLECULAR TARGETED THERAPY; RECEPTORS, LEPTIN; RECURRENCE; SIGNAL TRANSDUCTION; THROMBOSIS; VEINS; VENOUS THROMBOSIS;

EID: 84894097606     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990021     Document Type: Article

References (71)

1. Gelber RP, Gaziano JM, Orav EJ, et al. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol 2008; 52: 605-15.
2. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293: 1861-7.
3. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-49.
4. Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658-67.
5. Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493-6.
6. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
7. Fain JN, Madan AK, Hiler ML, et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-82.
8. Guh DP, Zhang W, Bansback N, et al. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
9. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-49.
10. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
11. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-61.
12. Konstantinides S, Schäfer K, Koschnick S, et al. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533-40.
13. Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-6.
14. Soderberg S, Ahren B, Jansson JH, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409-18.
15. Wolk R, Berger P, Lennon RJ, et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44: 1819-24.
16. Soderberg S, Stegmayr B, Stenlund H, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 2004; 256: 128-36.
17. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. Am J Cardiol 2007; 100: 234-39.
18. Soderberg S, Colquhoun D, Keech A, et al. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes (Lond) 2009; 33: 123-30.
19. Sattar N, Wannamethee G, Sarwar N, et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 2009; 53: 167-75.
20. Luc G, Empana JP, Morange P, et al. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study. Int J Obes (Lond) 2010; 34: 118-26.
21. Bodary PF, Westrick RJ, Wickenheiser KJ, et al. Effect of leptin on arterial thrombosis following vascular injury in mice. Jama-Journal of the American Medical Association 2002; 287: 1706-9.
22. Bodary PF, Gu S, Shen Y, et al. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25: e119-22.
23. Konstantinides S, Schäfer K, Neels JG, et al. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 2196-2201.
24. Bigalke B, Stellos K, Geisler T, et al. High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease. Platelets 2010; 21: 11-9.
25. Jose VJ, Mariappan P, George PV, et al. Serum leptin levels in acute myocardial infarction. Indian Heart J 2005; 57: 39-43.
26. Meisel SR, Ellis M, Pariente C, et al. Serum leptin levels increase following acute myocardial infarction. Cardiology 2001; 95: 206-11.
27. Matsuno H, Kozawa O, Niwa M, et al. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery. Thromb Haemost 1998; 79: 865-71.
28. Massberg S, Vogt F, Dickfeld T, et al. Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res 2003; 110: 187-94.
29. Langer H, May AE, Daub K, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006; 98: e2-10.
30. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-41.
31. Schäfer K, Halle M, Goeschen C, et al. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004; 24: 112-7.
32. Qasim A, Mehta NN, Tadesse MG, et al. Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol 2008; 52: 231-6.
33. Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25: 805-10.
34. Piatti P, Di Mario C, Monti LD, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with instent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074-81.
35. Nakata M, Yada T, Soejima N, et al. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48: 426-9.
36. Dellas C, Schäfer K, Rohm IK, et al. Leptin signalling and leptinmediated activation of human platelets: importance of JAK2 and the phospholipases Cgamma2 and A2. Thromb Haemost 2007; 98: 1063-71.
37. Wallaschofski H, Kobsar A, Sokolova O, et al. Differences in platelet activation by prolactin and leptin. Horm Metab Res 2004; 36: 453-7.
38. Giandomenico G, Dellas C, Czekay RP, et al. The leptin receptor system of human platelets. J Thromb Haemost 2005; 3: 1042-9.
39. Corsonello A, Malara A, De Domenico D, et al. Identifying pathways involved in leptin-dependent aggregation of human platelets. Int J Obes Relat Metab Disord 2004; 28: 979-84.
40. Elbatarny HS, Maurice DH. Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex. Am J Physiol Endocrinol Metab 2005; 289: E695-702.
41. Wannamethee SG, Tchernova J, Whincup P, et al. Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007; 191: 418-26.
42. Guagnano MT, Romano M, Falco A, et al. Leptin increase is associated with markers of the hemostatic system in obese healthy women. J Thromb Haemost. 2003; 1: 2330-4.
43. Lijnen HR, Van Hul M, Hemmeryckx B. Caloric restriction improves coagulation and inflammation profile in obese mice. Thromb Res 2012; 129: 74-9.
44. Rafail S, Ritis K, Schäfer K, et al. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFalpha involvement. Thromb Res 2008; 122: 366-75.
45. Napoleone E, DI Santo A, Amore C, et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost 2007; 5: 1462-8.
46. Kopp CW, Kopp HP, Steiner S, et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res 2003; 11: 950-6.
47. Cirillo P, Angri V, De Rosa S, et al. Pro-atherothrombotic effects of leptin in human coronary endothelial cells. Thromb Haemost 2010; 103: 1065-75.
48. Soderberg S, Olsson T, Eliasson M, et al. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 1999; 245: 533-43.
49. Singh P, Peterson TE, Barber KR, et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells. Biochem Biophys Res Commun 2010; 392: 47-52.
50. Schroeter MR, Stein S, Heida NM, et al. Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9. Cardiovasc Res 2012; 93: 170-80.
51. Heida NM, Leifheit-Nestler M, Schroeter MR, et al. Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin alphaVbeta5: implications for angiogenesis in human obesity. Arterioscler Thromb Vasc Biol 2010; 30: 200-6.
52. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-6.
53. Heida NM, Müller JP, Cheng IF, et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010; 55: 357-7.
54. Tobler K, Freudenthaler A, Baumgartner-Parzer SM, et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond) 2010; 34: 687-700.
55. Huang W, Dedousis N, Bhatt BA, et al. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J Biol Chem 2004; 279: 21695-700.
56. Corsonello A, Perticone F, Malara A, et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 2003; 27: 566-73.
57. Dellas C, Schäfer K, Rohm I, et al. Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity. Thromb Haemost 2008; 100: 1123-9.
58. Sugiyama C, Ishizawa M, Kajita K, et al. Platelet aggregation in obese and diabetic subjects: association with leptin level. Platelets 2007; 18: 128-34.
59. Howard JK, Cave BJ, Oksanen LJ, et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10: 734-8.
60. Mori H, Hanada R, Hanada T, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 2004; 10: 739-43.
61. Kaszubska W, Falls HD, Schaefer VG, et al. Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line. Mol Cell Endocrinol 2002; 195: 109-18.
62. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2002; 2: 489-95.
63. Ozata M, Avcu F, Durmus O, et al. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obes Res 2001; 9: 627-30.
64. Corica F, Corsonello A, Lucchetti M, et al. Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients. Int J Obes (Lond) 2007; 31: 842-9.
65. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-84.
66. Fujikawa T, Chuang JC, Sakata I, et al. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA 2010; 107: 17391-6.
67. Wang MY, Chen L, Clark GO, et al. Leptin therapy in insulindeficient type I diabetes. Proc Natl Acad Sci USA 2010; 107: 4813-9.
68. Barbeau P, Gutin B, Litaker MS, et al. Influence of physical training on plasma leptin in obese youths. Can J Appl Physiol 2003; 28: 382-96.
69. Murakami T, Horigome H, Tanaka K, et al. Effects of diet with or without exercise on leptin and anticoagulation proteins levels in obesity. Blood Coagul Fibrinolysis 2007; 18: 389-94.
70. Reseland JE, Anderssen SA, Solvoll K, et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001; 73: 240-5.
71. Canavan B, Salem RO, Schurgin S, et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J Clin Endocrinol Metab 2005; 90: 5779-85.